That sounds like a sad story. I’m sorry to hear that you have had such a lack of success. One ray of hope... stick with AVXL and maybe your luck will change.
Totally agree. Missling is far from being forthcoming with information that share holders deserve and need. The best we can hope for is a buyout and a BP that can capitalize on the science and get the drug to market.
News 
Market Data 
Discover 
